Sponsor:
Stanford University
Code:
NCT04899544
Conditions
Autism
Autism Spectrum Disorder
ASD
Eligibility Criteria
Sex: All
Age: 2 - 5
Healthy Volunteers: Not accepted
Interventions
Center-Based Pivotal Response Treatment (PRT) Intervention (PRT-C)
Home-Based Pivotal Response Treatment (PRT Intervention (PRT-H)
Brief summary:
Conditions
Autism
Autism Spectrum Disorder
ASD
Study ID
NCT04899544
Start date
Oct 18, 2022
Status verified date
Jun, 2026
Completion date
Sep 15, 2028
Anticipated
Primary completion date
Sep 15, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 2 - 5
Healthy Volunteers: Not accepted
Enrollment
120 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Center-Based Pivotal Response Treatment (PRT) Intervention (PRT-C)
experimental: Home-Based Pivotal Response Treatment (PRT) Intervention (PRT-H)
no intervention: Treatment As Usual (TAU)
Interventions
Center-Based Pivotal Response Treatment (PRT) Intervention (PRT-C)
Home-Based Pivotal Response Treatment (PRT Intervention (PRT-H)
Primary outcome measure
Central contacts
Locations
Stanford University School of Medicine
Recruiting
Stanford, California, United States, 94305
Contacts
Principal Investigator:
Antonio Y Hardan, MD
Sponsor
Stanford University
Last update posted
Jun 24, 2026
Last verified
Jun, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Stanford University on 2026-06-24.